Work

Faculty Opinions recommendation of The mevalonate pathway is a druggable target for vaccine adjuvant discovery.

Year: 2018

Type: peer-review

Source: Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature

DOI: 10.3410/f.734088275.793553444

Author: Roberto Docampo

Institution: University of Georgia

Language: English

Topic: Immunotherapy and Immune Responses

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4234345128

Cites:

Cited by:

Related to: 10